Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMPS
10151
PUT
Compass Pathways
CMPS
$1.86B
| $161K | ﹤0.01% |
21,800
+1,500
| +7% | +$13.3K |
|
10152
PUT
Energy Recovery
ERII
$426M
| $161K | ﹤0.01% |
7,600
+4,000
| +111% | +$107K |
|
10153
CALL
Bionano Genomics
BNGO
$13.9M
| $161K | ﹤0.01% |
886
+236
| +36% | +$61.8K |
|
10154
RAVE Restaurant Group
RAVE
$43.2M
| $160K | ﹤0.01% |
67,682
+38,913
| +135% | +$80.4K |
|
|
WE
10155
PUT
DELISTED
WeWork Inc.
WE
| $160K | ﹤0.01% |
53,270
+38,515
| +261% | +$264K |
|
|
HEPS
10156
D-Market Electronic Services & Trading
HEPS
$997M
| $160K | ﹤0.01% |
120,488
-32,599
| -21% | -$50.1K |
|
10157
CALL
DNOW Inc
DNOW
$2.97B
| $160K | ﹤0.01% |
13,500
-6,900
| -34% | -$77K |
|
|
ATXS
10158
DELISTED
Astria Therapeutics
ATXS
| $160K | ﹤0.01% |
21,449
+21,014
| +4,831% | +$179K |
|
10159
CALL
Sabesp
SBS
$16.2B
| $160K | ﹤0.01% |
68,066
+36,611
| +116% | +$83.2K |
|
|
NRT
10160
North European Oil Royalty Trust
NRT
$82M
| $160K | ﹤0.01% |
13,095
+3,021
| +30% | +$39.3K |
|
|
OPLN
10161
PUT
Openlane
OPLN
$4.33B
| $160K | ﹤0.01% |
10,700
-13,600
| -56% | -$209K |
|
|
PVLA
10162
Palvella Therapeutics
PVLA
$2.25B
| $160K | ﹤0.01% |
6,695
-18,278
| -73% | -$393K |
|
|
RAPT
10163
PUT
DELISTED
RAPT Therapeutics
RAPT
| $160K | ﹤0.01% |
1,200
+525
| +78% | +$85.7K |
|
10164
PUT
Compass Diversified
CODI
$956M
| $160K | ﹤0.01% |
8,500
-12,800
| -60% | -$269K |
|
|
ONTF
10165
CALL
DELISTED
ON24
ONTF
| $160K | ﹤0.01% |
25,200
-17,600
| -41% | -$130K |
|
10166
Carlyle Secured Lending
CGBD
$781M
| $159K | ﹤0.01% |
10,988
-14,868
| -58% | -$223K |
|
10167
PUT
Relmada Therapeutics
RLMD
$512M
| $159K | ﹤0.01% |
53,100
-23,800
| -31% | -$70.7K |
|
10168
PUT
Brady Corp
BRC
$4.44B
| $159K | ﹤0.01% |
2,900
+1,000
| +53% | +$51.5K |
|
|
KWY
10169
Kingsway Corp
KWY
$285M
| $159K | ﹤0.01% |
+21,095
| New | +$176K |
|
|
QQQH
10170
PUT
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$387M
| $159K | ﹤0.01% |
3,950
+3,900
| +7,800% | +$165K |
|
10171
CALL
IDEAYA Biosciences
IDYA
$3.49B
| $159K | ﹤0.01% |
5,900
-2,200
| -27% | -$55.8K |
|
10172
PUT
DMC Global
BOOM
$155M
| $159K | ﹤0.01% |
6,500
-12,700
| -66% | -$276K |
|
|
CITE
10173
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $159K | ﹤0.01% |
14,763
-2,731
| -16% | -$29.2K |
|
10174
CALL
Rekor Systems
REKR
$98.2M
| $159K | ﹤0.01% |
56,300
+38,700
| +220% | +$118K |
|
10175
PUT
DT Midstream
DTM
$14B
| $159K | ﹤0.01% |
3,000
-4,000
| -57% | -$209K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.